Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248197 | SCV000316116 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000248197 | SCV000338724 | benign | not specified | 2016-03-15 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000302782 | SCV000450115 | likely benign | Ellis-van Creveld syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000404157 | SCV000484090 | benign | Curry-Hall syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000302782 | SCV000484091 | benign | Ellis-van Creveld syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000248197 | SCV000516522 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Breakthrough Genomics, |
RCV004710673 | SCV005256682 | likely benign | not provided | criteria provided, single submitter | not provided |